In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS)

In Vivo

Volumn 15, Issue 5, 2001, Pages 365-371

  Papadopoulou, M V ^a   Pouremad, R ^a   Rao, M K ^a   Ji, M ^a   Bloomer, W D ^a  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

19F magnetic resonance spectroscopy; Bioreductive drugs; Hypoxic markers; NLTQ 1

Indexed keywords

1 (1,1,1,3,3,3 HEXAFLUORO 2 PROPOXY) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 2 (2 NITRO 1 IMIDAZOLYL) N (3,3,3 TRIFLUORO 2 HYDROXYPROPYL)ACETAMIDE; 2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 2 NITROIMIDAZOLE; 4 [3 (2 NITRO 1 IMIDAZOLYL)PROPYLAMINO] 7 TRIFLUOROMETHYLQUINOLINE; 7 TRIFLUOROMETHYLQUINOLINE; BIOLOGICAL MARKER; FLUORINE; NUCLEIC ACID; PROTEIN; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; BINDING KINETICS; CELL LEVEL; CELL LINE; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; COVALENT BOND; DISEASE MARKER; DRUG METABOLISM; DRUG SELECTIVITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; FLUORINATION; HAMSTER; HYPOXIA; HYPOXIC CELL; IN VITRO STUDY; ISOTOPE LABELING; MACROMOLECULE; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TUMOR CELL;

EID: 0034766882     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Misonidazole and other hypoxia markers: Metabolism and applications
2. Effects of low flow and hypoxia on myocardial retention of technetium-99m BMS 181321
3. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumors
4. Fluorescent markers for hypoxic cells: A comparison of two compounds on three cell lines
5. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells
6. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro
7. Covalent binding of a fluorinated 2-nitroimidazole to EMT6 tumors in BALB/c mice: Detection by F-19 nuclear magnetic resonance at 2.35 T
8. Pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed fluorinated 2-nitroimidazole probe SR-4554 for the detection of hypoxia by magnetic resonance spectroscopy
9. 19F magnetic resonance spectroscopy in vivo
10. 2 at the cellular level
11. The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: Reductive metabolism and semi-quantitative localization in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis
12. Non-invasive MRS in new anticancer drug development
13. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-)-2-nitro-1-imidazolyl)Acetamide (SR-4554) as a probe for the measurement of tumor hypoxia
14. Nitroheterocyclic-linked acridines as DNA-targeting bioreductive agents
15. 9-(3-(2-Nitro-1-imidazolyl)propylamino) cyclopenteno(b)quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer
16. A new substituent constant, p, derived from partition coefficients
17. Mechanism of resistance of non-cycling mammalian cells to 4′-(9-acridylamino)-methanesulfon-m-anisidide: Comparison of uptake, metabolism, and DNA breakage in log and plateau-phase Chinese hamster fibroblast cell cultures